Faecal concentrations of piperacillin and tazobactam in elderly patients [9]

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 1, 2001, Pages 155-156

  Wilcox, M H ^a   Brown, A ^a   Freeman, J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; UREIDOPENICILLIN;

AGED; BACTERIAL INFECTION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DRUG ACCUMULATION; DRUG EXCRETION; DRUG FECES LEVEL; FEMALE; HUMAN; LETTER; MALE; SEPSIS;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENZYME INHIBITORS; FECES; FEMALE; HUMANS; MALE; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN;

EID: 0034914332     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: A four-year survey in a general hospital
2. Epidemiology, clinical manifestations, and outcome of Clostridium difficile diarrhoea
3. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam
4. Effect of piperacillin-tazobactam treatment on human bowel microflora
5. Colonization resistance of the human intestinal microflora: Testing the hypothesis in normal volunteers
6. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam